0000899243-16-012535.txt : 20160202 0000899243-16-012535.hdr.sgml : 20160202 20160202161545 ACCESSION NUMBER: 0000899243-16-012535 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160201 FILED AS OF DATE: 20160202 DATE AS OF CHANGE: 20160202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Clovis Oncology, Inc. CENTRAL INDEX KEY: 0001466301 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 900475355 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5500 FLATIRON PARKWAY STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: (303) 625-5000 MAIL ADDRESS: STREET 1: 5500 FLATIRON PARKWAY STREET 2: SUITE 100 CITY: BOULDER STATE: CO ZIP: 80301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hooks Corwin Dale CENTRAL INDEX KEY: 0001665347 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35347 FILM NUMBER: 161381056 MAIL ADDRESS: STREET 1: C/O CLOVIS ONCOLOGY, INC. STREET 2: 5500 FLATIRON PARKWAY CITY: BOULDER STATE: CO ZIP: 80301 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2016-02-01 0 0001466301 Clovis Oncology, Inc. CLVS 0001665347 Hooks Corwin Dale C/O CLOVIS ONCOLOGY, INC. 5500 FLATIRON PARKWAY BOULDER CO 80301 0 1 0 0 See remarks Common Stock 703 D Stock option (right to buy) 46.68 2024-08-25 Common Stock 50000 D Stock option (right to buy) 79.05 2025-03-02 Common Stock 5600 D The option vested as to 25% of the shares on August 25, 2015, and the remainder shall vest in substantially equal installments over the 36 months immediately following such date. The option shall vest as to 25% of the shares on March 2, 2016, and the remainder shall vest in substantially equal installments over the 36 months immediately following such date. Senior Vice President and Chief Commercial Officer /s/ Corwin Dale Hooks 2016-02-01